Moderna
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Moderna's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 64% to $6,848,000,000. The net income dropped to -$4,714,000,000 and profit margin reached -69%. Total operating expenses were $6,394,000,000.

Profit Margin

Moderna, Inc. (NASDAQ:MRNA): Profit margin
2016 101.53M -216.21M -212.94%
2017 176.97M -255.91M -144.61%
2018 122.51M -384.73M -314.04%
2019 48.03M -514.02M -1070.07%
2020 274.49M -747.06M -272.16%
2021 17.73B 12.20B 68.8%
2022 19.26B 8.36B 43.41%
2023 6.84B -4.71B -68.84%

MRNA Income Statement (2016 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016
Revenue
Revenue
6.84B19.26B17.73B274.49M48.03M122.51M176.97M101.53M
Cost of revenue
4.69B5.41B2.61B7.93M31.02M454.08M20.53M0
Gross profit
2.15B13.84B15.11B266.55M17.01M-331.57M156.43M101.53M
Operating exp.
Research and development
4.84B3.29B1.99B1.37B496.30M454.08M410.45M274.71M
Selling and marketing
204M121M000000
Total operating expenses
6.39B4.42B1.82B1.02B593.75M535.77M446.33M325.30M
Operating income
-4.23B9.42B13.29B-763.14M-545.72M-413.26M-269.35M-223.77M
Other income (expenses), net
297M155M-11M18.63M31.00M1.83M13.36M-2.70M
Income before tax
-3.94B9.57B13.28B-744.51M-514.71M-384.40M-255.99M-215.16M
Income tax expense
772M1.21B1.08B2.55M-695K326K-80K1.04M
Net income
-4.71B8.36B12.20B-747.06M-514.02M-384.73M-255.91M-216.21M
Earnings per share
Basic EPS
-12.3421.2230.28-1.96-1.55-4.74-0.68-0.58
Diluted EPS
-12.3420.128.31-1.96-1.55-4.74-0.68-0.58
Data sourceData sourceData sourceData sourceData sourceData source